Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Paclitaxel-induced peripheral neuropathy in the study groups

From: Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial

  Peripheral neuropathy
  Normal Mild Moderate Severe Total
Omega- 3 supplemented group 21(70%) 4(13.3%) 5(16.7%) 0% 30(100%)
Placebo received group 11(40.7%) 10(37%) 5(18.5%) 1(3.7%) 27(100%)
  1. A significant difference in PN incidence (OR = 0.3, .95% CI = (0.10 - 0.88), p = 0.029).
  2. No significant difference in severity of PN (B = −1.02, .95% CI = (−2.06 - 0.02), p = 0.054).
Back to article page